Pan J, Deng B, Liu S, et al. Efficacy and safety of CD22-directed CAR-T cell therapy in 15 pediatric refractory or relapsed B acute lymphoblastic leukemia patients. EHA 2018, abstract 832.
Allogene anti-CD19 CAR-T-celtherapie voor gerecidiveerde of refractaire B-cel ALL
dec 2022 | Leukemie